Mathematical modeling of apoptosis

Cell Communication and Signaling

Volumn 11, Issue 1, 2013, Pages

  Schleich, Kolja ^a   Lavrik, Inna N ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Cancer; Death receptors; Modeling; Systems biology

Indexed keywords

CASPASE 8; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; CANCER THERAPY; MATHEMATICAL MODEL; NECROPTOSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STOICHIOMETRY; SYSTEMS BIOLOGY; THEORETICAL MODEL;

EID: 84879458084     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-11-44     Document Type: Review

References (86)

1. Apoptosis in the pathogenesis and treatment of disease. Thompson CB, Science 1995 267 1456 1462 10.1126/science.7878464 7878464
2. Life and death in peripheral T cells. Krammer PH, Arnold R, Lavrik IN, Nat Rev Immunol 2007 7 532 542 10.1038/nri2115 17589543 (Pubitemid 46987784)
3. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME, EMBO J 1995 14 5579 5588 8521815
4. Caspase-9 and APAF-1 form an active holoenzyme. Rodriguez J, Lazebnik Y, Genes Dev 1999 13 3179 3184 10.1101/gad.13.24.3179 10617566 (Pubitemid 30030439)
5. Review: nuclear events in apoptosis. Robertson JD, Orrenius S, Zhivotovsky B, J Struct Biol 2000 129 346 358 10.1006/jsbi.2000.4254 10806085 (Pubitemid 30481376)
6. c-FLIPR, a new regulator of death receptor-induced apoptosis. Golks A, Brenner D, Fritsch C, Krammer PH, Lavrik IN, J Biol Chem 2005 280 14507 14513 10.1074/jbc.M414425200 15701649 (Pubitemid 40562792)
7. The protein structures that shape caspase activity, specificity, activation and inhibition. Fuentes-Prior P, Salvesen GS, Biochem J 2004 384 201 232 10.1042/BJ20041142 15450003 (Pubitemid 39656233)
8. Computational systems biology. Kitano H, Nature 2002 420 206 210 10.1038/nature01254 12432404 (Pubitemid 35340131)
9. Systems biology: a brief overview. Kitano H, Science 2002 295 1662 1664 10.1126/science.1069492 11872829 (Pubitemid 34202893)
10. Kitano H, Foundations of Systems Biology Cambridge: Mit Press 2001
11. Systems biology of apoptosis signaling networks. Lavrik IN, Curr Opin Biotechnol 2010 21 551 555 10.1016/j.copbio.2010.07.001 20674332
12. Understanding apoptosis by systems biology approaches. Lavrik IN, Eils R, Fricker N, Pforr C, Krammer PH, Mol Biosyst 2009 5 1105 1111 10.1039/b905129p 19756299
13. Systems Biology Approaches to the Study of Apoptosis. Huber H, Bullinger E, Rehm M, Essentials of Apoptosis New York, NY: Humana Press, Dong Z, Yin X-M, 2 2009 283 297
14. Systems Biology Analysis of Cell Death Pathways in Cancer: How Collaborative and Interdisciplinary Research Helps. Zhivotovsky B, Barillot E, Cancer Systems Biology, Bioinformatics and Medicine Springer Netherlands: Dordrecht, Cesario A, Marcus F, 2011
15. Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. Schleich K, Warnken U, Fricker N, Oztürk S, Richter P, Kammerer K, Schnölzer M, Krammer PH, Lavrik IN, Mol Cell 2012 47 306 319 10.1016/j.molcel.2012.05.006 22683265
16. A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death. Dickens LS, Boyd RS, Jukes-Jones R, Hughes MA, Robinson GL, Fairall L, Schwabe JWR, Cain K, MacFarlane M, Mol Cell 2012 47 291 305 10.1016/j.molcel.2012.05.004 22683266
17. Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis. Aldridge BB, Gaudet S, Lauffenburger DA, Sorger PK, Mol Syst Biol 2011 7 553 22108795
18. Properties of cell death models calibrated and compared using Bayesian approaches. Eydgahi H, Chen WW, Muhlich JL, Vitkup D, Tsitsiklis JN, Sorger PK, Mol Syst Biol 2013 9 644 23385484
19. Clinical application of a systems model of apoptosis execution for the prediction of colorectal cancer therapy responses and personalisation of therapy. Hector S, Rehm M, Schmid J, Kehoe J, McCawley N, Dicker P, Murray F, McNamara D, Kay EW, Concannon CG, et al. Gut 2012 61 725 733 10.1136/gutjnl-2011-300433 22082587
20. Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release. Huber HJ, Dussmann H, Kilbride SM, Rehm M, Prehn JHM, Mol Syst Biol 2011 7 470 21364572
21. Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks. Lee MJ, Ye AS, Gardino AK, Heijink AM, Sorger PK, MacBeath G, Yaffe MB, Cell 2012 149 780 794 10.1016/j.cell.2012.03. 031 22579283
22. Death Receptors: Signaling and Modulation. Ashkenazi A, Dixit VM, Science 1998 281 1305 1308 9721089 (Pubitemid 28406815)
23. CD95's deadly mission in the immune system. Krammer PH, Nature 2000 407 789 795 10.1038/35037728 11048730
24. Death receptor signaling. Lavrik I, Golks A, Krammer PH, J Cell Sci 2005 118 265 267 10.1242/jcs.01610 15654015 (Pubitemid 40277339)
25. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Trauth BC, Klas C, Peters AM, Matzku S, Möller P, Falk W, Debatin KM, Krammer PH, Science 1989 245 301 305 10.1126/science.2787530 2787530 (Pubitemid 19196649)
26. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME, EMBO J 1997 16 2794 2804 10.1093/emboj/16.10.2794 9184224 (Pubitemid 27226216)
27. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S, J Biol Chem 2001 276 20633 20640 10.1074/jbc.M101780200 11279218
28. The death domain Superfamily in Intracellular Signaling of Apoptosis and Inflammation. Park HH, Lo Y-C, Lin S-C, Wang L, Yang JK, Wu H, Annu Rev Immunol 2007 25 561 586 10.1146/annurev.immunol.25.022106.141656 17201679 (Pubitemid 46697917)
29. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. Chang DW, Xing Z, Pan Y, Algeciras-Schimnich A, Barnhart BC, Yaish-Ohad S, Peter ME, Yang X, EMBO J 2002 21 3704 3714 10.1093/emboj/cdf356 12110583 (Pubitemid 34787044)
30. The role of CAP3 in CD95 signaling: new insights into the mechanism of procaspase-8 activation. Golks A, Brenner D, Schmitz I, Watzl C, Krueger A, Krammer PH, Lavrik IN, Cell Death Differ 2006 13 489 498 10.1038/sj.cdd.4401766 16179941
31. Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Hughes MA, Harper N, Butterworth M, Cain K, Cohen GM, MacFarlane M, Mol Cell 2009 35 265 279 10.1016/j.molcel.2009.06.012 19683492
32. Mechanism of procaspase-8 activation by c-FLIPL. Yu JW, Jeffrey PD, Shi Y, Proc Natl Acad Sci U S A 2009 106 8169 8174 10.1073/pnas.0812453106 19416807
33. Caspases: pharmacological manipulation of cell death. Lavrik IN, Golks A, Krammer PH, J Clin Invest 2005 115 2665 2672 10.1172/JCI26252 16200200 (Pubitemid 41434390)
34. The role of c-FLIP in modulation of CD95-induced apoptosis. Scaffidi C, Schmitz I, Krammer PH, Peter ME, J Biol Chem 1999 274 1541 1548 10.1074/jbc.274.3.1541 9880531 (Pubitemid 29057975)
35. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation. Golks A, Brenner D, Krammer PH, Lavrik IN, J Exp Med 2006 203 1295 1305 10.1084/jem.20051556 16682493 (Pubitemid 43736598)
36. Up-regulation of c-FLIP short by NFAT contributes to apoptosis resistance of short-term activated T cells. Ueffing N, Schuster M, Keil E, Schulze-Osthoff K, Schmitz I, Blood 2008 112 690 698 10.1182/blood-2008-02-141382 18509086
37. Cellular FLICE-like inhibitory proteins (c-FLIPs): Fine-tuners of life and death decisions. Oztürk S, Schleich K, Lavrik IN, Exp Cell Res 2012 318 1324 1331 10.1016/j.yexcr.2012.01.019 22309778
38. Regulation of CD95/Fas signaling at the DISC. Lavrik IN, Krammer PH, Cell Death Differ 2012 19 36 41 10.1038/cdd.2011.155 22075988
39. Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL. Fricker N, Beaudouin J, Richter P, Eils R, Krammer PH, Lavrik IN, J Cell Biol 2010 190 377 389 10.1083/jcb.201002060 20696707
40. Mechanisms of apoptosis through structural biology. Yan N, Shi Y, Annu Rev Cell Dev Biol 2005 21 35 56 10.1146/annurev.cellbio.21.012704.131040 16212486 (Pubitemid 41740626)
41. Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis. Li H, Zhu H, Xu C, Yuan J, Cell 1998 94 491 501 10.1016/S0092-8674(00)81590-1 9727492 (Pubitemid 28391865)
42. The CD95 Type I/Type II model. Barnhart BC, Alappat EC, Peter ME, Semin Immunol 2003 15 185 193 10.1016/S1044-5323(03)00031-9 14563117 (Pubitemid 38155825)
43. IAP family proteins-suppressors of apoptosis. Deveraux QL, Reed JC, Genes Dev 1999 13 239 252 10.1101/gad.13.3.239 9990849
44. Mechanisms of Caspase Activation and Inhibition during Apoptosis. Shi Y, Mol Cell 2002 9 459 470 10.1016/S1097-2765(02)00482-3 11931755 (Pubitemid 34273778)
45. The Bcl-2 Protein Family: Arbiters of Cell Survival. Adams JM, Cory S, Science 1998 281 1322 1326 9735050 (Pubitemid 28406819)
46. Stimulation of Fas (CD95) induces production of pro-inflammatory mediators through ERK/JNK-dependent activation of NF-κB in THP-1 cells. Lee S-M, Kim E-J, Suk K, Lee W-H, Cell Immunol 2011 271 157 162 10.1016/j.cellimm.2011.06.019 21752354
47. CD95 promotes tumour growth. Chen L, Park S-M, Tumanov AV, Hau A, Sawada K, Feig C, Turner JR, Fu Y-X, Romero IL, Lengyel E, Peter ME, Nature 2010 465 492 496 10.1038/nature09075 20505730
48. The death receptor CD95 activates the cofilin pathway to stimulate tumour cell invasion. Steller EJ, Ritsma L, Raats DAE, Hoogwater FJH, Emmink BL, Govaert KM, Laoukili J, Borel Rinkes IHM, Van Rheenen J, Kranenburg O, EMBO Rep 2011 12 931 937 10.1038/embor.2011.129 21760611
49. Fas ligation and tumor necrosis factor alpha activation of murine astrocytes promote heat shock factor-1 activation and heat shock protein expression leading to chemokine induction and cell survival. Choi K, Ni L, Jonakait GM, J Neurochem 2011 116 448
50. Apoptosis promotes early tumorigenesis. Tang D, Lotze MT, Kang R, Zeh HJ, Oncogene 2011 30 1851 1854 10.1038/onc.2010.573 21151175
51. The many roles of FAS receptor signaling in the immune system. Strasser A, Jost PJ, Nagata S, Immunity 2009 30 180 192 10.1016/j.immuni.2009.01.001 19239902
52. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. Geserick P, Hupe M, Moulin M, Wong WW-L, Feoktistova M, Kellert B, Gollnick H, Silke J, Leverkus M, J Cell Biol 2009 187 1037 1054 10.1083/jcb.200904158 20038679
53. Caspase-8 and caspase-10 activate NF-kappaB through RIP, NIK and IKKalpha kinases. Shikama Y, Yamada M, Miyashita T, Eur J Immunol 2003 33 1998 2006 10.1002/eji.200324013 12884866 (Pubitemid 37120872)
54. Proliferative versus apoptotic functions of caspase-8 Hetero or homo: The caspase-8 dimer controls cell fate. Van Raam BJ, Salvesen GS, Biochim Biophys Acta 2012 1824 113 122 10.1016/j.bbapap.2011.06.005 21704196
55. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Neumann L, Pforr C, Beaudouin J, Pappa A, Fricker N, Krammer PH, Lavrik IN, Eils R, Mol Syst Biol 2010 6 352 20212524
56. Downregulation of c-FLIP promotes caspase-dependent JNK activation and reactive oxygen species accumulation in tumor cells. Nakajima A, Kojima Y, Nakayama M, Yagita H, Okumura K, Nakano H, Oncogene 2008 27 76 84 10.1038/sj.onc.1210624 17599041
57. Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activation. Kober AMM, Legewie S, Pforr C, Fricker N, Eils R, Krammer PH, Lavrik IN, Cell Death & Disease 2011 2 212 10.1038/cddis.2011.93 23807770
58. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J, Curr Biol 2000 10 640 648 10.1016/S0960-9822(00)00512-1 10837247 (Pubitemid 30354699)
59. NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. Kreuz S, Siegmund D, Rumpf J-J, Samel D, Leverkus M, Janssen O, Häcker G, Dittrich-Breiholz O, Kracht M, Scheurich P, Wajant H, J Cell Biol 2004 166 369 380 10.1083/jcb.200401036 15289496 (Pubitemid 39031240)
60. Discrete dynamic modeling of signal transduction networks. Saadatpour A, Albert R, Computational Modeling of Signaling Networks Totowa, NJ: Humana Press, Liu X, Betterton MD, 2012 255 272
61. Classic and contemporary approaches to modeling biochemical reactions. Chen WW, Niepel M, Sorger PK, Genes Dev 2010 24 1861 1875 10.1101/gad.1945410 20810646
62. Measuring and modeling apoptosis in single cells. Spencer SL, Sorger PK, Cell 2011 144 926 939 10.1016/j.cell.2011.03.002 21414484
63. Lavrik IN, Systems Biology of Apoptosis New York: Springer 1 2013
64. Studies concerning affinity. Waage P, Guldberg CM, J Chem Educ 1986 63 1044 10.1021/ed063p1044
65. Agent-based modeling: methods and techniques for simulating human systems. Bonabeau E, Proc Natl Acad Sci U S A 2002 99 Suppl 3 7280 7287 12011407 (Pubitemid 34522724)
66. Agent-based modeling and simulation. Macal CM, North MJ, Proceedings of the 2009 Winter Simulation Conference (WSC) 2009 86 98
67. Tutorial on agent-based modelling and simulation. Macal CM, North MJ, Journal of Simulation 2010 4 151 162 10.1057/jos.2010.3
68. An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Brown BN, Price IM, Toapanta FR, Dealmeida DR, Wiley CA, Ross TM, Oury TD, Vodovotz Y, Math Biosci 2011 231 186 196 10.1016/j.mbs.2011. 03.005 21385589
69. An Agent-Based Model to study the epidemiological and evolutionary dynamics of Influenza viruses. Roche B, Drake JM, Rohani P, BMC Bioinformatics 2011 12 87 10.1186/1471-2105-12-87 21450071
70. A mathematical model of caspase function in apoptosis. Fussenegger M, Bailey JE, Varner J, Nat Biotechnol 2000 18 768 774 10.1038/77589 10888847 (Pubitemid 30460695)
71. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. Bentele M, Lavrik I, Ulrich M, Stösser S, Heermann DW, Kalthoff H, Krammer PH, Eils R, J Cell Biol 2004 166 839 851 10.1083/jcb.200404158 15364960 (Pubitemid 39249835)
72. Bistability analyses of a caspase activation model for receptor-induced apoptosis. Eissing T, Conzelmann H, Gilles ED, Allgöwer F, Bullinger E, Scheurich P, J Biol Chem 2004 279 36892 36897 10.1074/jbc.M404893200 15208304 (Pubitemid 39129038)
73. Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. Legewie S, Blüthgen N, Herzel H, PLoS Comput Biol 2006 2 120 10.1371/journal.pcbi.0020120 16978046 (Pubitemid 44495720)
74. Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Saez-Rodriguez J, Alexopoulos LG, Epperlein J, Samaga R, Lauffenburger DA, Klamt S, Sorger PK, Mol Syst Biol 2009 5 331 19953085
75. ON/OFF and beyond - a boolean model of apoptosis. Schlatter R, Schmich K, Avalos Vizcarra I, Scheurich P, Sauter T, Borner C, Ederer M, Merfort I, Sawodny O, PLoS Comput Biol 2009 5 1000595 10.1371/journal.pcbi.1000595 20011108
76. Boolean network-based analysis of the apoptosis network: irreversible apoptosis and stable surviving. Mai Z, Liu H, J Theor Biol 2009 259 760 769 10.1016/j.jtbi.2009.04.024 19422837
77. Mathematical modelling of cell-fate decision in response to death receptor engagement. Calzone L, Tournier L, Fourquet S, Thieffry D, Zhivotovsky B, Barillot E, Zinovyev A, PLoS Comput Biol 2010 6 1000702 10.1371/journal.pcbi. 1000702 20221256
78. Prediction of caspase cleavage sites using Bayesian bio-basis function neural networks. Yang ZR, Bioinformatics 2005 21 1831 1837 10.1093/ bioinformatics/bti281 15671118 (Pubitemid 40668018)
79. Model validation of biological pathways using Petri nets-demonstrated for apoptosis. Heiner M, Koch I, Will J, Bio Systems 2004 75 15 28 10.1016/j.biosystems.2004.03.003 15245801 (Pubitemid 38887549)
80. Cellular automata modeling of FASL-initiated apoptosis. Apte A, Bonchev D, Fong S, Chem Biodivers 2010 7 1163 1172 10.1002/cbdv.200900422 20491073
81. Modeling of the role of a Bax-activation switch in the mitochondrial apoptosis decision. Chen C, Cui J, Lu H, Wang R, Zhang S, Shen P, Biophys J 2007 92 4304 4315 10.1529/biophysj.106.099606 17400705 (Pubitemid 46910545)
82. Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. Lavrik IN, Golks A, Riess D, Bentele M, Eils R, Krammer PH, J Biol Chem 2007 282 13664 13671 10.1074/jbc.M700434200 17347143 (Pubitemid 47100557)
83. Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. Rehm M, Huber HJ, Dussmann H, Prehn JHM, EMBO J 2006 25 4338 4349 10.1038/sj.emboj.7601295 16932741 (Pubitemid 44435231)
84. APOPTO-CELL-a simulation tool and interactive database for analyzing cellular susceptibility to apoptosis. Huber HJ, Rehm M, Plchut M, Düssmann H, Prehn JHM, Bioinformatics 2007 23 648 650 10.1093/bioinformatics/btl684 17237051 (Pubitemid 46522606)
85. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Albeck JG, Burke JM, Aldridge BB, Zhang M, Lauffenburger DA, Sorger PK, Mol Cell 2008 30 11 25 10.1016/j.molcel.2008.02.012 18406323 (Pubitemid 351470145)
86. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK, Nature 2009 459 428 432 10.1038/nature08012 19363473